Abstract
Cerebrovascular disease is a major public health problem; over the next 10 years approximately 15 million people will suffer an acute stroke in Europe and the United States [1]. There is a clear need for more effective treatments both to prevent stroke and to treat the acute event. There has, in response to this, been a substantial increase in interest in the design, methodology and analysis of randomised controlled trials in cerebrovascular disease in recent years [2,3]. Indeed, trials have changed clinical practice in the primary prevention of stroke, e.g. treatment of hypertension [4]; the secondary prevention of stroke, e.g. antiplatelet treatment [5], anticoagulation [6], and carotid endarterectomy [7,8]; rehabilitation following stroke, e.g. stroke units [8]; and in the treatment of acute stroke, e.g. Nimodipine in subarachnoid haemorrhage [9] and more recently aspirin [10,11] and thrombolytic therapy [12] in cerebral infarction. There are trials in progress of many other potentially promising treatments such as angioplasty for symptomatic carotid stenosis [13] and neuroprotective treatments for acute ischaemic stroke [3].
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sandercock PAG, Celani MG, Ricci S. The likely public health impact in Europe of simple treatments for acute ischaemic stroke. Cerebrovasc Dis 1992; 2: 236.
Bogousslaysky J. O Acute stroke trials: from morass to nirvana? Cerebrovasc Dis 1995; 5: 3–6.
Dorman PJ, Sandercock PAG. Considerations in the design of clinical trials of neuroprotective therapy in acute stroke. Stroke 1996; 27: 1507–1515.
Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart disease. Part 2, short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–838.
Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81–106.
European Atrial Fibrillation Trial Study Group. Secondary prevention in nonrheumatic atrial fibrillation transient ischaemic attack or minor stroke. Lancet 1993; 342: 213–220.
European Carotid Surgery Trialists’ Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 1991; 337: 1235–1243.
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445–453.
Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome following subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989; 298: 636–642.
International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349: 1569–1581.
Chinese Acute Stroke Trial Collaborative Group. CAST: a randomised placebo controlled trial of early aspirin use in 20000 patients with acute ischaemic stroke. Lancet 1997; 349: 1641 1649.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 1995; 333: 1581–1587.
Major ongoing stroke trials. Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS). Stroke 1996; 27: 358.
Harrison MJG. Ethics of stroke trials. In: Amery WK, Bousser M-G, Clifford-Rose F, editors. Clinical trial methodology in stroke. London: Baillière Tindall, 1989: 267–281.
Stiller CA. Centralised treatment, entry to trials and survival. Br J Cancer 1994; 70: 352–362.
Counsell C, Salinas R, Naylor R, Warlow C. The role of routine or selective carotid artery shunting during carotid endarterectomy and the different methods of monitoring in selective shunting. The Cochrane Library. London: BMJ Publishing, 1997.
LaRue LJ, Alter M, Traven ND, et al. Acute stroke therapy trials: problems in patient accrual. Stroke 1988; 19: 950–954.
Steiner TJ, Clifford Rose F. Towards a model stroke trial. The single centre naftidrofuryl study. Neuroepidemiology 1986; 5: 121–147.
Gorringe JAL. Initial preparartion for clinical trials. In: Harris EL, Fitzgerald JD, editors. The principles and practice of clinical trials. Edinburgh: Churchill Livingstone, 1970: 41–46.
Woods KL. Megatrials and management of acute myocardial infarction. Lancet 1995; 346: 611–614.
Rothwell PM. Can overall results of clinical trials be applied to all patients? Lancet 1995; 345: 1616–1619.
Yusef S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stat Med 1984; 3: 409–420.
UK-TIA study group. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54: 1044–1054.
Hankey GJ, Dennis MS, Slattery J, Warlow CP. Why is the outcome of transient ischaemic attacks different in different groups of patients? BMJ 1993; I: 1107–1111.
Hier DB, Edelstein G. Deriving clinical prediction rules from stroke outcome research. Stroke 1991; 22: 1431–1436.
Hankey GJ, Slattery JM, Warlow CP. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events? J Neurol Neurosurg Psychiatry 1992; 55: 640652.
Rothwell PM, Slattery J, Warlow CP. A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke 1996; 27: 260–265.
Norton B, Homer-Ward M, Donnelly MT, Long RG, Holmes GKT. A randomised prospective comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding after acute dysphagic stroke. BMJ 1996; 312: 13–16.
Kraaijeveld CL, van Gijn J, Schouten HJA, Staal A. Interobserver agreement for the diagnosis of transient ischaemic attacks. Stroke 1984; 15: 723–725.
Hansen M, Sindrup SH, Christensen PB, Olsen NK, Kristensen O, Friis ML. Interobserver variation in the evaluation of neurological signs: observer dependent factors. Acta Neurol Scand 1994; 90: 145–149.
Noseworthy JH, Ebers GC, Vandervoort MK, Farquhar RE, Yetisir E, Roberts R. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology 1994; 44: 16–20.
Kotila M, Waltimo O, Niemi ML, et al. The profile of recovery from stroke and factors influencing outcome. Stroke 1984; 15: 1039–1044.
Skilbeck CE, Wade DT, Langton-Hewer R, Wood VA. Recovery after stroke. J Neurol Neurosurg Psychiatry 1983; 46: 5–8.
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421–1428.
Hobson RW, Weiss DG, et al. and the Veterans Affairs Cooperative study group. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993; 328: 22 1227.
Warlow CP. Endarterectomy for asymptomatic carotid steno-sis? Lancet 1995; 345: 1254–1255.
van Gijn J, Warlow C. Down with stroke scales. Cerebrovasc Dis 1992; 2: 244–246.
Mahoney FI, Barthel DW. Functional evaluation. The Barthel Index. Md State Med 1965; 14: 61–65.
Granger CV, Sherwood CC, Greer DS. Functional status measures in comprehensive stroke care program. Arch Phys Med Rehabil 1977; 58: 555–561.
Granger CV, Dewis LS, Peters MC, et al. Stroke rehabilitation: analysis of repeated Barthel index measures. Arch Phys Med Rehabil 1979; 60: 14–17.
Van Swieten JC, Koudstaal PJ, Schouten HJA, van Gijn J. Inter-observer agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604–607.
Lindley RI, Waddell F, Livingstone M, Warlow C, Dennis M, Sandercock P, Smith B. Can simple questions assess outcome after stroke? Cerebrovasc Dis 1994; 4: 314–324.
Brazier JE, Harper R, Jones NMB, O’Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305: 160–164.
Dorman PJ, Slattery J, Farrell B, Dennis MS. A randomised comparison of the EuroQol and Short-Form 36 after stroke. BMJ 1997; 315: 461.
The EuroQol Group. Euroqol: a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199–208.
Koudstaal PJ. Stroke prevention in non-valvular atrial fibrillation. Some methodological aspects. In: Amery WK, Bousser M-G, Clifford Rose F, editors. Clinical trial methodology in stroke. London: Baillière Tindall, 1989.
Warlow C. How to do it: Organise a multicentre trial. BMJ 1990; 300: 180–183.
Candelise L. Clinical trial methodology in stroke multicentre studies: keep the protocol simple. In: Amery WK, Bousser M-G, Clifford Rose F, editors. Clinical trial methodology in stroke. London: Baillière Tindall, 1989.
Canadian Cooperative Study Group. A randomised trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299: 53–59.
Rothwell PM, Slattery J, Warlow CP. A systematic review of clinical and angiographic predictors of stroke and death due to carotid endarterectomy. BMJ 1997; 315: 1571–1577.
Ricci S, Celani MG, Righetti E, Cantisani AT for the International Stroke Trial Collaborative Group. Between country variations in the use of medical treatments for acute stroke: An update. Cerebrovasc Dis 1996; 6 (Suppl 2): 133.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag London
About this chapter
Cite this chapter
Rothwell, P.M. (2001). Cerebrovascular Disease: Basic Designs, Sample Sizes and Pitfalls. In: Guiloff, R.J. (eds) Clinical Trials in Neurology. Springer, London. https://doi.org/10.1007/978-1-4471-3787-0_17
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3787-0_17
Publisher Name: Springer, London
Print ISBN: 978-1-84996-856-0
Online ISBN: 978-1-4471-3787-0
eBook Packages: Springer Book Archive